Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Gray matter differences in patients with functional movement disorders.

Maurer CW, LaFaver K, Limachia GS, Capitan G, Ameli R, Sinclair S, Epstein SA, Hallett M, Horovitz SG.

Neurology. 2018 Oct 10. pii: 10.1212/WNL.0000000000006514. doi: 10.1212/WNL.0000000000006514. [Epub ahead of print]

PMID:
30305450
2.

Collateral circulation assessment within the 4.5 h time window in patients with and without DWI/FLAIR MRI mismatch.

Berthezène Y, Eker O, Makris N, Bettan M, Mansuy A, Chabrol A, Mikkelsenm IK, Hermier M, Mechtouff L, Ong E, Derex L, Berner LP, Ameli R, Pedraza S, Thomalla G, Østergaard L, Baron JC, Cho TH, Nighoghossian N.

J Neurol Sci. 2018 Nov 15;394:94-98. doi: 10.1016/j.jns.2018.09.013. Epub 2018 Sep 12.

PMID:
30240943
3.

Impact of the Thrombectomy Trials on the Management and Outcome of Large Vessel Stroke: Data From the Lyon Stroke Center.

Viannay L, Haesebaert J, Florin F, Riva R, Mechtouff L, Gory B, Ong E, Labeyrie PE, Derex L, Hermier M, Chamard L, Berner LP, Ameli R, Berthezène Y, Turjman F, Nighoghossian N, Cho TH.

Front Neurol. 2018 Aug 28;9:722. doi: 10.3389/fneur.2018.00722. eCollection 2018.

4.

Objective Evaluation of Multiple Sclerosis Lesion Segmentation using a Data Management and Processing Infrastructure.

Commowick O, Istace A, Kain M, Laurent B, Leray F, Simon M, Pop SC, Girard P, Améli R, Ferré JC, Kerbrat A, Tourdias T, Cervenansky F, Glatard T, Beaumont J, Doyle S, Forbes F, Knight J, Khademi A, Mahbod A, Wang C, McKinley R, Wagner F, Muschelli J, Sweeney E, Roura E, Lladó X, Santos MM, Santos WP, Silva-Filho AG, Tomas-Fernandez X, Urien H, Bloch I, Valverde S, Cabezas M, Vera-Olmos FJ, Malpica N, Guttmann C, Vukusic S, Edan G, Dojat M, Styner M, Warfield SK, Cotton F, Barillot C.

Sci Rep. 2018 Sep 12;8(1):13650. doi: 10.1038/s41598-018-31911-7.

5.

Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials.

Ballard ED, Wills K, Lally N, Richards EM, Luckenbaugh DA, Walls T, Ameli R, Niciu MJ, Brutsche NE, Park L, Zarate CA Jr.

J Affect Disord. 2017 Aug 15;218:195-200. doi: 10.1016/j.jad.2017.04.057. Epub 2017 Apr 25.

6.

Impaired self-agency in functional movement disorders: A resting-state fMRI study.

Maurer CW, LaFaver K, Ameli R, Epstein SA, Hallett M, Horovitz SG.

Neurology. 2016 Aug 9;87(6):564-70. doi: 10.1212/WNL.0000000000002940. Epub 2016 Jul 6.

7.

Insights into Chronic Functional Movement Disorders: The Value of Qualitative Psychiatric Interviews.

Epstein SA, Maurer CW, LaFaver K, Ameli R, Sinclair S, Hallett M.

Psychosomatics. 2016 Nov - Dec;57(6):566-575. doi: 10.1016/j.psym.2016.04.005. Epub 2016 Apr 29.

8.

Impaired resting vagal tone in patients with functional movement disorders.

Maurer CW, Liu VD, LaFaver K, Ameli R, Wu T, Toledo R, Epstein SA, Hallett M.

Parkinsonism Relat Disord. 2016 Sep;30:18-22. doi: 10.1016/j.parkreldis.2016.06.009. Epub 2016 Jun 16.

9.

A Wireless Optogenetic Headstage with Multichannel Electrophysiological Recording Capability.

Gagnon-Turcotte G, Kisomi AA, Ameli R, Camaro CO, LeChasseur Y, Néron JL, Bareil PB, Fortier P, Bories C, de Koninck Y, Gosselin B.

Sensors (Basel). 2015 Sep 9;15(9):22776-97. doi: 10.3390/s150922776.

10.

Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant.

Ballard ED, Luckenbaugh DA, Richards EM, Walls TL, Brutsché NE, Ameli R, Niciu MJ, Vande Voort JL, Zarate CA Jr.

J Psychiatr Res. 2015 Sep;68:68-73. doi: 10.1016/j.jpsychires.2015.06.003. Epub 2015 Jun 16.

11.

A biological measure of stress levels in patients with functional movement disorders.

Maurer CW, LaFaver K, Ameli R, Toledo R, Hallett M.

Parkinsonism Relat Disord. 2015 Sep;21(9):1072-5. doi: 10.1016/j.parkreldis.2015.06.017. Epub 2015 Jun 21.

12.

Flexible, Polarization-Diverse UWB Antennas for Implantable Neural Recording Systems.

Bahrami H, Mirbozorgi SA, Ameli R, Rusch LA, Gosselin B.

IEEE Trans Biomed Circuits Syst. 2016 Feb;10(1):38-48. doi: 10.1109/TBCAS.2015.2393878. Epub 2015 Mar 16.

13.

Rating depression over brief time intervals with the Hamilton Depression Rating Scale: standard vs. abbreviated scales.

Luckenbaugh DA, Ameli R, Brutsche NE, Zarate CA Jr.

J Psychiatr Res. 2015 Feb;61:40-5. doi: 10.1016/j.jpsychires.2014.12.015. Epub 2014 Dec 27.

14.

Towards a wireless optical stimulation system for long term in-vivo experiments.

Mirbozorgi SA, Ameli R, Sawan M, Gosselin B.

Conf Proc IEEE Eng Med Biol Soc. 2014;2014:2024-7. doi: 10.1109/EMBC.2014.6944013.

PMID:
25570381
15.

Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression.

Lally N, Nugent AC, Luckenbaugh DA, Ameli R, Roiser JP, Zarate CA.

Transl Psychiatry. 2014 Oct 14;4:e469. doi: 10.1038/tp.2014.105.

16.

Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.

Ballard ED, Ionescu DF, Vande Voort JL, Niciu MJ, Richards EM, Luckenbaugh DA, Brutsché NE, Ameli R, Furey ML, Zarate CA Jr.

J Psychiatr Res. 2014 Nov;58:161-6. doi: 10.1016/j.jpsychires.2014.07.027. Epub 2014 Aug 12.

17.

SHAPS-C: the Snaith-Hamilton pleasure scale modified for clinician administration.

Ameli R, Luckenbaugh DA, Gould NF, Holmes MK, Lally N, Ballard ED, Zarate CA Jr.

PeerJ. 2014 Jun 17;2:e429. doi: 10.7717/peerj.429. eCollection 2014.

18.

A wireless and batteryless neural headstage with optical stimulation and electrophysiological recording.

Ameli R, Mirbozorgi A, Neron JL, Lechasseur Y, Gosselin B.

Conf Proc IEEE Eng Med Biol Soc. 2013;2013:5662-5. doi: 10.1109/EMBC.2013.6610835.

PMID:
24111022
19.

Response inhibition in motor conversion disorder.

Voon V, Ekanayake V, Wiggs E, Kranick S, Ameli R, Harrison NA, Hallett M.

Mov Disord. 2013 May;28(5):612-8. doi: 10.1002/mds.25435. Epub 2013 Apr 2.

20.

Psychopathology and psychogenic movement disorders.

Kranick S, Ekanayake V, Martinez V, Ameli R, Hallett M, Voon V.

Mov Disord. 2011 Aug 15;26(10):1844-50. doi: 10.1002/mds.23830. Epub 2011 Jun 28.

21.

Psychiatric symptoms associated with focal hand dystonia.

Voon V, Butler TR, Ekanayake V, Gallea C, Ameli R, Murphy DL, Hallett M.

Mov Disord. 2010 Oct 15;25(13):2249-52. doi: 10.1002/mds.23250.

22.

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.

DiazGranados N, Ibrahim LA, Brutsche NE, Ameli R, Henter ID, Luckenbaugh DA, Machado-Vieira R, Zarate CA Jr.

J Clin Psychiatry. 2010 Dec;71(12):1605-11. doi: 10.4088/JCP.09m05327blu. Epub 2010 Jul 13.

23.

Emotional stimuli and motor conversion disorder.

Voon V, Brezing C, Gallea C, Ameli R, Roelofs K, LaFrance WC Jr, Hallett M.

Brain. 2010 May;133(Pt 5):1526-36. doi: 10.1093/brain/awq054. Epub 2010 Apr 5.

24.

Posttraumatic growth in former Vietnam prisoners of war.

Feder A, Southwick SM, Goetz RR, Wang Y, Alonso A, Smith BW, Buchholz KR, Waldeck T, Ameli R, Moore J, Hain R, Charney DS, Vythilingam M.

Psychiatry. 2008 Winter;71(4):359-70. doi: 10.1521/psyc.2008.71.4.359.

PMID:
19152285
25.

Elevated fear conditioning to socially relevant unconditioned stimuli in social anxiety disorder.

Lissek S, Levenson J, Biggs AL, Johnson LL, Ameli R, Pine DS, Grillon C.

Am J Psychiatry. 2008 Jan;165(1):124-32. Epub 2007 Nov 15.

26.

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK.

Arch Gen Psychiatry. 2006 Aug;63(8):856-64.

PMID:
16894061
27.

A neuropsychological assessment of phobias in patients with stiff person syndrome.

Ameli R, Snow J, Rakocevic G, Dalakas MC.

Neurology. 2005 Jun 14;64(11):1961-3.

PMID:
15955955
28.

Conditioned inhibition of fear-potentiated startle and skin conductance in humans.

Grillon C, Ameli R.

Psychophysiology. 2001 Sep;38(5):807-15.

PMID:
11577904
29.

Contextual fear-potentiated startle conditioning in humans: replication and extension.

Ameli R, Ip C, Grillon C.

Psychophysiology. 2001 May;38(3):383-90.

PMID:
11352126
30.

Effects of alcohol on baseline startle and prepulse inhibition in young men at risk for alcoholism and/or anxiety disorders.

Grillon C, Sinha R, Ameli R, O'Malley SS.

J Stud Alcohol. 2000 Jan;61(1):46-54.

PMID:
10627096
31.

Effects of threat of shock, shock electrode placement and darkness on startle.

Grillon C, Ameli R.

Int J Psychophysiol. 1998 May;28(3):223-31.

PMID:
9545658
32.

A neural network simulation of hallucinated "voices" and associated speech perception impairments in schizophrenic patients.

Hoffman RE, Rapaport J, Ameli R, McGlashan TH, Harcherik D, Servan-Schreiber D.

J Cogn Neurosci. 1995 Fall;7(4):479-96. doi: 10.1162/jocn.1995.7.4.479.

PMID:
23961906
33.

P300 assessment of anxiety effects on processing novel stimuli.

Grillon C, Ameli R.

Int J Psychophysiol. 1994 Aug;17(3):205-17.

PMID:
7806465
34.

Baseline and fear-potentiated startle in panic disorder patients.

Grillon C, Ameli R, Goddard A, Woods SW, Davis M.

Biol Psychiatry. 1994 Apr 1;35(7):431-9.

PMID:
8018793
35.

Safety signals and human anxiety: a fear-potentiated startle study.

Grillon C, Falls WA, Ameli R, Davis M.

Anxiety. 1994;1(1):13-21.

PMID:
9160541
36.

Measuring the time course of anticipatory anxiety using the fear-potentiated startle reflex.

Grillon C, Ameli R, Merikangas K, Woods SW, Davis M.

Psychophysiology. 1993 Jul;30(4):340-6.

PMID:
8327619
37.

Fear-potentiated startle: relationship to the level of state/trait anxiety in healthy subjects.

Grillon C, Ameli R, Foot M, Davis M.

Biol Psychiatry. 1993 Apr 15-May 1;33(8-9):566-74.

PMID:
8329489
38.

Startle gating deficits occur across prepulse intensities in schizophrenic patients.

Grillon C, Ameli R, Charney DS, Krystal J, Braff D.

Biol Psychiatry. 1992 Nov 15;32(10):939-43.

PMID:
1467378
39.

The promise of partial hospitalization: a reassessment.

Hoge MA, Davidson L, Hill WL, Turner VE, Ameli R.

Hosp Community Psychiatry. 1992 Apr;43(4):345-54. Review.

PMID:
1577425
40.

Fear-potentiated startle in humans: effects of anticipatory anxiety on the acoustic blink reflex.

Grillon C, Ameli R, Woods SW, Merikangas K, Davis M.

Psychophysiology. 1991 Sep;28(5):588-95.

PMID:
1758934
41.

Middle latency auditory evoked potentials (MAEPs) in chronic schizophrenics.

Grillon C, Ameli R, Braff DL.

Schizophr Res. 1991 Jul-Aug;5(1):61-6.

PMID:
1677265
42.

N400 and semantic categorization in schizophrenia.

Grillon C, Ameli R, Glazer WM.

Biol Psychiatry. 1991 Mar 1;29(5):467-80.

PMID:
2018820
43.

Effects of task relevance and attention on P3 in schizophrenic patients.

Grillon C, Ameli R, Courchesne E, Braff DL.

Schizophr Res. 1991 Jan-Feb;4(1):11-21.

PMID:
2009252
44.

Brainstem auditory-evoked potentials to different rates and intensities of stimulation in schizophrenics.

Grillon C, Ameli R, Glazer WM.

Biol Psychiatry. 1990 Nov 1;28(9):819-23. No abstract available.

PMID:
2257287
45.

Effects of rare non-target stimuli on brain electrophysiological activity and performance.

Grillon C, Courchesne E, Ameli R, Elmasian R, Braff D.

Int J Psychophysiol. 1990 Oct;9(3):257-67.

PMID:
2276944
46.

Increased distractibility in schizophrenic patients. Electrophysiologic and behavioral evidence.

Grillon C, Courchesne E, Ameli R, Geyer MA, Braff DL.

Arch Gen Psychiatry. 1990 Feb;47(2):171-9.

PMID:
2302027
47.

Visual memory processes in high-functioning individuals with autism.

Ameli R, Courchesne E, Lincoln A, Kaufman AS, Grillon C.

J Autism Dev Disord. 1988 Dec;18(4):601-15.

PMID:
3215886

Supplemental Content

Support Center